APA (7th ed.) Citation

WC, D., MB, W., J, S., M, P., AS, S., TS, A., . . . MD, K. (2020). CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study. Journal of cardiothoracic and vascular anesthesia, 34(1), 20. https://doi.org/10.1053/j.jvca.2019.09.003

Chicago Style (17th ed.) Citation

WC, Dunham, et al. "CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study." Journal of Cardiothoracic and Vascular Anesthesia 34, no. 1 (2020): 20. https://doi.org/10.1053/j.jvca.2019.09.003.

MLA (9th ed.) Citation

WC, Dunham, et al. "CYP2D6 Genotype-guided Metoprolol Therapy in Cardiac Surgery Patients: Rationale and Design of the Pharmacogenetic-guided Metoprolol Management for Postoperative Atrial Fibrillation in Cardiac Surgery (PREEMPTIVE) Pilot Study." Journal of Cardiothoracic and Vascular Anesthesia, vol. 34, no. 1, 2020, p. 20, https://doi.org/10.1053/j.jvca.2019.09.003.